Medical disease names should be reflective of the pathophysiologic processes underlying them. Medical education has propagated the use of outdated eponyms when referring to diseases named after individuals who discovered or described the diseases in question. This is confusing and harmful to medical students learning about these diseases and can present a seemingly insurmountable barrier to understanding complex pathologies. The renaming of diseases that are colloquially referred to by individuals' names is proposed. Medical schools are encouraged to adopt this nomenclature so that students will effectively understand pathophysiology and eventually provide optimal patient care. While it is not feasible to be completely systematic in this approach, striving for this change will enable a spotlight to shine on the disease and not the individuals who popularized the condition. Numerous examples are given of diseases that are either appropriately or inappropriately named, with recommendations for renaming given where applicable. An exploration of the benefits and disadvantages of renaming includes both historical and modern contexts for making the change.

Download full-text PDF

Source
http://dx.doi.org/10.1080/0142159X.2023.2277133DOI Listing

Publication Analysis

Top Keywords

medical education
8
diseases
5
call medical
4
education reconsider
4
reconsider disease
4
disease eponyms
4
medical
4
eponyms medical
4
medical disease
4
disease names
4

Similar Publications

Objective: Evaluate Department of Defense (DoD) antimicrobial stewardship programs (ASPs) by assessing the relationship between key clinical outcome metrics (antibiotic use, incidence of resistant pathogens, and incidence of infections) and CDC Core Element (CE) adherence.

Design: Retrospective, cross-sectional study of DoD hospitals in 2018 and 2021.

Methods: National Healthcare Safety Network Standardized Antimicrobial Administration Ratios (SAARs) were used to measure antibiotic use and microbiology results to evaluate four types of pathogen incidence.

View Article and Find Full Text PDF

Introduction: Colorectal cancer (CRC) incidence is increasing in Uganda. Despite this, and the disproportionately high burden of early onset and late-stage CRC cases, no CRC screening program exists in Uganda. To guide and inform future CRC prevention efforts, interviews with key stakeholders were undertaken to better understand the perceived barriers and opportunities relevant to the development and implementation of a CRC screening program in Uganda.

View Article and Find Full Text PDF

Loss of N-6 adenine-specific DNA methyltransferase 1 leads to meiotic prophase abnormalities and male sub-fertility in mice.

Biol Reprod

March 2025

The Institute of Cardiovascular Sciences, School of Basic Medical Sciences; Key Laboratory of Environment and Genes Related to Diseases, Ministry of Education, Xi'an Jiaotong University, Xi'an, Shaanxi, China.

Mammalian sexual reproduction critically relies on the generation of haploid gametes following a specialized cell division process known as meiosis. Here, we demonstrate that N-6 Adenine-Specific DNA methyltransferase 1 (N6AMT1) plays a crucial role in the progression of meiosis during spermatogenesis, as follows. N6AMT1 was expressed in germ cells throughout the entire process of spermatogenesis, with a peak in mRNA levels in spermatocytes at the prophase I stage of meiosis.

View Article and Find Full Text PDF

Advances in Polymer-Based Self-Adjuvanted Nanovaccines.

Small

March 2025

Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Centre for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu, 610041, P. R. China.

Nanovaccines, as a new generation of vaccines, have garnered significant interest due to their exceptional potential in enhancing disease prevention and treatment. Their unique features, such as high stability, antigens protection, prolonged retention, and targeted delivery to lymph nodes, immune cells, and tumors, set them apart as promising candidates in the field of immunotherapy. Polymers, with their superior degradability, capacity to mimic pathogen characteristics, and surface functionality that facilitates modifications, serve as ideal carriers for vaccine components.

View Article and Find Full Text PDF

Prospect of extracellular vesicles in tumor immunotherapy.

Front Immunol

March 2025

Department of Reproductive Medicine, Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education, West China Second University Hospital of Sichuan University, Chengdu, China.

Extracellular vesicles (EVs), as cell-derived small vesicles, facilitate intercellular communication within the tumor microenvironment (TME) by transporting biomolecules. EVs from different sources have varied contents, demonstrating differentiated functions that can either promote or inhibit cancer progression. Thus, regulating the formation, secretion, and intake of EVs becomes a new strategy for cancer intervention.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!